Shares of NexGel, Inc. (NASDAQ:NXGL – Free Report) are scheduled to reverse split on the morning of Monday, October 12th. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, October 11th.
NexGel Price Performance
Shares of NXGL stock traded down $0.03 on Thursday, reaching $0.15. 1,312,856 shares of the company were exchanged, compared to its average volume of 501,067. The company has a market cap of $1.46 million, a price-to-earnings ratio of -0.21 and a beta of 0.82. The business has a 50-day moving average price of $0.31 and a 200 day moving average price of $0.48. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.27 and a current ratio of 0.43. NexGel has a 1 year low of $0.15 and a 1 year high of $2.89.
NexGel (NASDAQ:NXGL – Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.28). The company had revenue of $3.69 million for the quarter, compared to analyst estimates of $4.32 million. NexGel had a negative return on equity of 121.18% and a negative net margin of 51.26%. Equities research analysts forecast that NexGel will post -0.94 earnings per share for the current fiscal year.
Analyst Ratings Changes
Read Our Latest Stock Analysis on NexGel
Institutional Inflows and Outflows
A hedge fund recently bought a new position in NexGel stock. Empery Asset Management LP purchased a new stake in NexGel, Inc. (NASDAQ:NXGL – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 90,000 shares of the company’s stock, valued at approximately $3,474,000. Empery Asset Management LP owned about 0.98% of NexGel as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 2.21% of the company’s stock.
NexGel Company Profile
NexGel, Inc develops and manufactures high-water-content, electron-beam-crosslinked aqueous polymer hydrogels. Its products are designed to provide electrical conductivity, moisture retention, cushioning, and cooling for a range of medical, consumer, and industrial applications.
The company’s hydrogel products are used in medical electrodes for applications such as electrocardiography, neuromuscular stimulation, and defibrillation, as well as in ultrasound procedures. NexGel also supplies nonconductive hydrogels for wound care, burn care, scar treatment, and cosmetic products, along with specialized formulations for veterinary and other commercial uses.
Based in Langhorne, Pennsylvania, NexGel serves customers through business-to-business relationships with medical-device manufacturers and other product companies.
Further Reading
- Five stocks we like better than NexGel
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.
